MiNK Therapeutics Inc
For the period ended Mar 31, 2024. Filed May 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 14, 2024
INKT$10.35+3.0%Stored close · as of Nov 6, 2026
Contents
Legal Proceedings
Item 1. Legal Proceedings.
We are not a party to any material legal proceedings.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.